The attractive value proposition for our compound is: NeuMedics authored and was issued a patent for NM108 and it’s derivatives. It … Read More...
Value Propostion
Market Opportunity
Of the 3 currently accepted approaches for the treatment of DME: 1) focal laser 2) steroids, and 3) anti-VEGF, none are optimal, none fully … Read More...
Crowd Funding Activity
NeuMedics is actively listed on crowd funding sites, Healthios, Gust, and Angel MD. Proceeds from these sources will be used to advance … Read More...